chr18-21384325-G-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_001142966.3(GREB1L):​c.277G>A​(p.Glu93Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00415 in 1,551,744 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 17 hom. )

Consequence

GREB1L
NM_001142966.3 missense

Scores

2
6
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 9.14
Variant links:
Genes affected
GREB1L (HGNC:31042): (GREB1 like retinoic acid receptor coactivator) Acts upstream of or within kidney development. Predicted to be integral component of membrane. Implicated in autosomal dominant nonsyndromic deafness and renal agenesis. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), GREB1L. . Gene score misZ 5.3659 (greater than the threshold 3.09). Trascript score misZ 5.6738 (greater than threshold 3.09). GenCC has associacion of gene with bilateral renal agenesis, renal hypodysplasia/aplasia 3, renal agenesis, unilateral, hearing loss, autosomal dominant 80.
BP4
Computational evidence support a benign effect (MetaRNN=0.0039663613).
BP6
Variant 18-21384325-G-A is Benign according to our data. Variant chr18-21384325-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 917910.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00308 (469/152320) while in subpopulation NFE AF= 0.00501 (341/68030). AF 95% confidence interval is 0.00457. There are 2 homozygotes in gnomad4. There are 215 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 469 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GREB1LNM_001142966.3 linkuse as main transcriptc.277G>A p.Glu93Lys missense_variant 4/33 ENST00000424526.7 NP_001136438.1
LOC101927521XR_001753366.2 linkuse as main transcriptn.245-3650C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GREB1LENST00000424526.7 linkuse as main transcriptc.277G>A p.Glu93Lys missense_variant 4/335 NM_001142966.3 ENSP00000412060 Q9C091-1
ENST00000584611.1 linkuse as main transcriptn.289+3188C>T intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00308
AC:
469
AN:
152202
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000941
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00501
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00260
AC:
410
AN:
157698
Hom.:
0
AF XY:
0.00264
AC XY:
220
AN XY:
83278
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00239
Gnomad ASJ exome
AF:
0.00270
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000307
Gnomad FIN exome
AF:
0.00112
Gnomad NFE exome
AF:
0.00460
Gnomad OTH exome
AF:
0.00360
GnomAD4 exome
AF:
0.00427
AC:
5976
AN:
1399424
Hom.:
17
Cov.:
31
AF XY:
0.00414
AC XY:
2856
AN XY:
690226
show subpopulations
Gnomad4 AFR exome
AF:
0.000855
Gnomad4 AMR exome
AF:
0.00235
Gnomad4 ASJ exome
AF:
0.00294
Gnomad4 EAS exome
AF:
0.0000280
Gnomad4 SAS exome
AF:
0.000189
Gnomad4 FIN exome
AF:
0.00140
Gnomad4 NFE exome
AF:
0.00506
Gnomad4 OTH exome
AF:
0.00387
GnomAD4 genome
AF:
0.00308
AC:
469
AN:
152320
Hom.:
2
Cov.:
32
AF XY:
0.00289
AC XY:
215
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000938
Gnomad4 AMR
AF:
0.00334
Gnomad4 ASJ
AF:
0.00260
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00122
Gnomad4 NFE
AF:
0.00501
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00454
Hom.:
0
Bravo
AF:
0.00300
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00727
AC:
28
ESP6500AA
AF:
0.000723
AC:
1
ESP6500EA
AF:
0.00534
AC:
17
ExAC
AF:
0.00206
AC:
52
Asia WGS
AF:
0.000866
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2024GREB1L: PP2, BS1 -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Mayer-Rokitansky-Kuster-Hauser syndrome;C4540497:Renal hypodysplasia/aplasia 3 Uncertain:1
Uncertain significance, criteria provided, single submitterresearchHuman Genetic Laboratory, University of LiegeFeb 20, 2020The variant is in a gene (GREB1L) previously associated with renal and uterine malformations in human.The variant is reported in Gnomad with a MAF:0.002813 and is reported once at a homozygous state. The variant affects a moderately conserved nucleotide and poorly conserved aminoacid. In silico prediction are conflicting. We have identified this heterozygous variant in one individual with MRKH syndrome type 1 (sequencing not performed in the parents); one individual with MRKH type 2, mild caliectasis, vertebral anomalies and imperforate anus (sequencing not performed in the parents); and in two fetuses with uterovaginal aplasia, bilateral renal agenesis, ureter and bladder agenesis as well as their asymptomatic father (in cis with the variant c.3970-20A>G in GREB1L). -
GREB1L-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 07, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.011
T;.;T
Eigen
Uncertain
0.58
Eigen_PC
Pathogenic
0.66
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D;D;.
M_CAP
Benign
0.0058
T
MetaRNN
Benign
0.0040
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;L;L
MutationTaster
Benign
1.0
D;D;D;D;N
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-2.2
N;N;.
REVEL
Benign
0.20
Sift
Uncertain
0.0050
D;D;.
Sift4G
Uncertain
0.0080
D;D;D
Polyphen
0.87
P;.;P
Vest4
0.28
MVP
0.20
ClinPred
0.024
T
GERP RS
5.3
Varity_R
0.31
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs185578147; hg19: chr18-18964286; COSMIC: COSV104580625; API